Literature DB >> 25917666

Conventional and 3-Dimensional Computerized Tomography in Eagle's Syndrome, Glossopharyngeal Neuralgia, and Asymptomatic Controls.

David T Kent1, Tanya J Rath2, Carl Snyderman1.   

Abstract

OBJECTIVE: Eagle's syndrome (ES) is an aggregate of symptoms, including recurrent throat pain, foreign body sensation, dysphagia, or facial pain related to an elongated styloid process (SP). It resembles glossopharyngeal neuralgia and has been linked to irritation of the glossopharyngeal nerve. This study was designed to determine whether computerized tomography (CT) imaging of the stylohyoid chain (SHC) differs between asymptomatic controls (ACs), patients with glossopharyngeal neuralgia (GN), and patients with ES. STUDY
DESIGN: Case series with chart review.
SETTING: Tertiary otolaryngology practice. SUBJECTS AND METHODS: Conventional and 3-dimensional CT reconstructions of the SHC were reviewed for 10 ES, 17 GN, and 30 AC patients. Demographic and clinical symptom data were recorded. Anatomic data collected from CT scans included length of the ossified SP, anterior-posterior and medial-lateral styloid process angulation, ossification pattern of the SHC, and minimum distances between the SP tip, the internal carotid artery, and the tonsillar fossa.
RESULTS: The average distance from the SP tip to the tonsillar fossa was significantly shorter in ES (12.7 mm) compared with GN (21.4 mm; P = .027) or AC (24.8 mm; P < .0005) patients. No other variables were significantly different between groups, including average SP length (ES: 48.0 vs GN: 40.3 vs AC: 40 mm; P > .05).
CONCLUSION: The SP was significantly closer to the tonsillar fossa in patients with ES compared with ACs. No significant differences were found in other measures. Distance to the tonsillar fossa may be a more appropriate diagnostic criterion for ES than SP length and may contribute to the pathophysiology of ES. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  3D-CT; Eagle’s syndrome; computerized tomography; glossopharyngeal neuralgia; stylohyoid chain; styloid process

Mesh:

Year:  2015        PMID: 25917666     DOI: 10.1177/0194599815583047

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Eagle Syndrome Secondary to Osteoradionecrosis of the Styloid Process.

Authors:  Anna K Bareiss; David Z Cai; Amit S Patel; Brian A Moore
Journal:  Ochsner J       Date:  2017

2.  Morphometric analysis of the stylohyoid complex.

Authors:  Sladjana Petrović; Ivan Jovanović; Sladjana Ugrenović; Zoran Radovanović; Zoran Pešić; Ivica Vučković; Nikola Stojković; Filip Petrović
Journal:  Surg Radiol Anat       Date:  2016-10-12       Impact factor: 1.246

3.  Angulation of the ossified stylohyoid complex and Eagle syndrome.

Authors:  Fatma Caylakli
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-21       Impact factor: 2.503

4.  Surgical management of Eagle's syndrome: an approach to shooting craniofacial pain.

Authors:  Yoshihiko Kumai; Tadashi Hamasaki; Eiji Yumoto
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-22       Impact factor: 2.503

Review 5.  Pediatric glossopharyngeal neuralgia: a comprehensive review.

Authors:  Rafik Shereen; Brady Gardner; Juan Altafulla; Emily Simonds; Joe Iwanaga; Zachary Litvack; Marios Loukas; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2018-10-25       Impact factor: 1.475

6.  Eagle's Syndrome, from clinical presentation to diagnosis and surgical treatment: a case report.

Authors:  S Saccomanno; F Greco; E DE Corso; D Lucidi; R Deli; A D'Addona; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

7.  Anatomical and Surgical Study to Evaluate the Accuracy of "C-M-S" Technique in Facial Nerve Identification During Parotid Surgery.

Authors:  Ashish S Shah; Satish Nair; V Pavithra; J G Aishwarya; K V R Brijith; Deeksha Thakur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.